These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 606422

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effect of 1alpha-hydroxyvitamin D3 in pre-dialysis renal bone disease.
    Pierides AM, Ellis HA, Simpson W, Cook D, Kerr DN.
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():109s-116s. PubMed ID: 606409
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Iliac bone marrow mast cells in relation to the renal osteodystrophy of patients treated by haemodialysis.
    Ellis HA, Peart KM.
    J Clin Pathol; 1976 Jun; 29(6):502-16. PubMed ID: 939806
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Experience with 1,25-dihydroxycholecalciferol therapy in undergoing hemodialysis patients with progressive vitamin D2-treated osteodystrophy.
    Prior JC, Cameron EC, Ballon HS, Lirenman DS, Moriarty MV, Price JD.
    Am J Med; 1979 Oct; 67(4):583-9. PubMed ID: 386792
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of renal bone disease.
    Lancet; 1979 Oct; 2(8156-8157):1339-40. PubMed ID: 92678
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
    Voigts AL, Felsenfeld AJ, Llach F.
    Arch Intern Med; 1983 Jun; 143(6):1205-11. PubMed ID: 6344827
    [Abstract] [Full Text] [Related]

  • 14. Periosteal new bone formation (periosteal neostosis) in renal osteodystrophy. Relationship to osteosclerosis, osteitis fibrosa, and osteoid excess.
    Meema HE, Oreopoulos DG, Rabinovich S, Husdan H, Rapoport A.
    Radiology; 1974 Mar; 110(3):513-22. PubMed ID: 4204516
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum alkaline phosphatase in azotemic and hemodialysis osteodystrophy: a study of isoenzyme patterns, their correlation with bone histology, and their changes in response to treatment with 1alphaOHD3 and 1,25(OH)2D3.
    Pierides AM, Skillen AW, Ellis HA.
    J Lab Clin Med; 1979 Jun; 93(6):899-909. PubMed ID: 438610
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Histomorphometric study of bone tissue in chronic renal failure].
    Kontek M.
    Pol Arch Med Wewn; 1980 Apr; 63(4):363-73. PubMed ID: 7413466
    [No Abstract] [Full Text] [Related]

  • 19. Use of 1,25(OH)2-vitamin D3 to separate 'types' on renal osteodystrophy.
    Coburn JW, Brickman AS, Sherrard DJ, Singer FR, Wong EG, Baylink DJ, Norman AW.
    Proc Eur Dial Transplant Assoc; 1977 Apr; 14():442-50. PubMed ID: 600961
    [Abstract] [Full Text] [Related]

  • 20. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
    Chazan JA, Libbey NP, London MR, Pono L, Abuelo JG.
    Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.